Emily Stone
Impact in
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
-
- Monoclonal and Polyclonal Antibodies Research
- Radiomics and Machine Learning in Medical Imaging
Papers in
-
- Lung Cancer Diagnosis and Treatment 18
- Lung Cancer Treatments and Mutations 9
- Oncology 21
- Global Cancer Incidence and Screening 12
- Cancer survivorship and care 4
- Co-authors
- Florian J. Fintelmann (1 shared paper)Scott Adams (1 shared paper)Rozemarijn Vliegenthart (1 shared paper)David Baldwin (1 shared paper)Pyng Lee (2 shared papers)Nicole Rankin (19 shared papers)C. Roger MacKenzie (3 shared papers)Jianbing Zhang (3 shared papers)
- Journals
- Respirology (10 papers)Translational Lung Cancer Research (5 papers)Journal of Thoracic Oncology (5 papers)PLoS ONE (2 papers)Antimicrobial Agents and Chemotherapy (2 papers)
- Partner nations
- AustraliaUnited StatesUnited Kingdom
In The Last Decade
Emily Stone
60 papers receiving 1.1k citations
Emily Stone's Hit Papers
Peers
Comparison fields: 5 of 112
- Molecular Medicine 71
- Radiology, Nuclear Medicine and Imaging 255
- Pulmonary and Respiratory Medicine 263
- Applied Microbiology and Biotechnology 16
- Oncology 157
Countries citing papers authored by Emily Stone
This map shows the geographic impact of Emily Stone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily Stone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily Stone more than expected).
Fields of papers citing papers by Emily Stone
This network shows the impact of papers produced by Emily Stone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily Stone. The network helps show where Emily Stone may publish in the future.
Co-authors
The 25 scholars most cited alongside Emily Stone, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 66 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Lung cancer screening Hit paper breakdown → | 2022 | 250 |
| 2 | 2003 | 136 | |
| 3 | 2011 | 110 | |
| 4 | 2019 | 54 | |
| 5 | 2018 | 52 | |
| 6 | 2018 | 51 | |
| 7 | 2006 | 50 | |
| 8 | 2019 | 37 | |
| 9 | 2004 | 37 | |
| 10 | 2016 | 34 | |
| 11 | 2017 | 32 | |
| 12 | 2018 | 22 | |
| 13 | 2022 | 18 | |
| 14 | 2019 | 18 | |
| 15 | 2014 | 14 | |
| 16 | 2016 | 14 | |
| 17 | 2022 | 12 | |
| 18 | 2022 | 12 | |
| 19 | 2018 | 12 | |
| 20 | 2019 | 10 |
About Emily Stone
Emily Stone is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Radiology, Nuclear Medicine and Imaging, Physiology and Molecular Biology, having authored 66 papers that have together received 1.1k indexed citations. Recurring topics across this work include Lung Cancer Diagnosis and Treatment (18 papers), Global Cancer Incidence and Screening (12 papers), Lung Cancer Treatments and Mutations (9 papers), Smoking Behavior and Cessation (6 papers), Radiomics and Machine Learning in Medical Imaging (5 papers), Cancer survivorship and care (4 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Glycosylation and Glycoproteins Research (2 papers). The work is most often cited by research in Molecular Medicine (71 citations), Radiology, Nuclear Medicine and Imaging (255 citations), Pulmonary and Respiratory Medicine (263 citations), Applied Microbiology and Biotechnology (16 citations) and Oncology (157 citations). Emily Stone has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Florian J. Fintelmann, Scott Adams, Rozemarijn Vliegenthart, David Baldwin, Pyng Lee, Nicole Rankin, C. Roger MacKenzie, Jianbing Zhang, Craig Lewis and Tomoko Hirama. Their work appears in journals such as Respirology, Translational Lung Cancer Research, Journal of Thoracic Oncology, PLoS ONE and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.